Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,075,761
+$234,728 QoQ
Shares Held
4,275
+10.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,029
of 1,872 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOEY INVESTMENTS, INC holds $4,107,250 across 15 Drug Manufacturers - General names. ABBV ranks #2 (26.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
4,928 | $1,784,527 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
4,275 | $1,075,761 | |
| 3 | JNJ |
Johnson & Johnson
|
2,250 | $571,432 | |
| 4 | GSK |
GSK plc
|
4,897 | $256,700 | |
| 5 | LLY |
ELI LILLY & Co
|
187 | $224,293 | |
| 6 | PFE |
Pfizer Inc
|
5,827 | $140,314 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
300 | $17,286 | |
| 8 | AZN |
Astrazeneca PLC
|
77 | $14,600 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,075,761 | 4,275 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $841,033 | 3,867 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $837,872 | 3,667 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $726,340 | 3,137 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $402,238 | 2,167 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $852,746 | 4,070 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $696,584 | 3,920 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $668,272 | 3,384 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $580,423 | 3,384 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $614,041 | 3,372 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $584,546 | 3,772 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $550,329 | 3,692 | Shares | Sole | 2024-04-22 | |
| 2023-06-30 | $182,559 | 1,355 | Shares | Sole | 2024-04-22 | |
| 2023-03-31 | $231,086 | 1,450 | Shares | Sole | 2024-04-22 | |
| 2022-12-31 | $298,978 | 1,850 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $194,604 | 1,450 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $191,450 | 1,250 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $283,692 | 1,750 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $169,250 | 1,250 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $134,837 | 1,250 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $84,480 | 750 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $81,165 | 750 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $80,362 | 750 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $65,692 | 750 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $122,725 | 1,250 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $26,666 | 350 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||